DEPOSEL MULTIDOSE 50 MG/ML SUSPENSION FOR INJECTIO
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
26-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
SELENIUM
Available from:
Novartis Animal Health UK Ltd
ATC code:
QA12CE
Dosage:
50 Mg/Ml
Pharmaceutical form:
Suspension for Injection
Therapeutic group:
Vitamins & Minerals
Therapeutic area:
Bovine
Authorization date:
2010-04-16
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA:10825/025/001
Case No: 7000077
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
NOVARTIS ANIMAL HEALTH UK LTD
FRIMLEY BUSINESS PARK, FRIMLEY, SURREY GU16 7SR, ENGLAND
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
DEPOSEL MULTIDOSE 50 MG/ML SUSPENSION FOR INJECTION
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in Part 2 of the said Schedule.
This authorisation,unless previously revoked, shall continue in force from 16/04/2010 to 15/04/2015.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 20/04/2010_
_CRN 7000077_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Deposel Multidose 50 mg/ml Suspension for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Suspension for injection.
Smooth, yellow aqueous suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and prevention of selenium deficiency in sheep and cattle for up to 12 months.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not exceed the recommended dosage.
ACTIVE INGREDIENTS:
Selen
Read the complete document
